-
Estrogen for Younger Postmenopausal Women; Warfarin Better for Atrial Fibrillation Patients; FDA Actions
-
Nearly one year following an in-depth report in the Wall Street Journal, and a brief synopsis in IDA (see June 2006, C. Kemper), this author, who was involved in the FDA review of telithromycin, provides a closer look at the events leading up to and following the FDA approval of telithromycin in the United States.
-
While use of aminoglycosides to treat gram negative rods has fallen over the last 30 years due to the availability of broad-spectrum beta lactam antibiotics, aminoglycoside antibiotics remain useful for the treatment of some life-threatening infections.
-
Lyme disease is the most commonly reported vector-borne disease in the U.S., with approximately 20,000 new cases reported each year. Most cases occur in northeastern, mid-Atlantic, and north central states (see Map), with peak incidences among those ages 5 to 14 years and 45 to 54 years.
-
-
In the past decade, prolongation of the QT interval associated with polymorphic ventricular tachycardia, or torsades de pointes (TdP), has accounted for the majority of withdrawals or restriction of the use of prescription drugs from the U.S. market.
-
The FDA recently approved retapamulin (ALTABAX ) for topical treatment of impetigo due to Staphylococcus aureus and Streptococcus pyogenes in adults and in children 9 months of age or greater.
-
Chronic obstructive pulmonary disease (COPD) is one of the few diseases whose incidence and prevalence is actually increasing in the United States.
-
-
SSRIs are associated with a low rate of birth defects according to 2 new studies in the New England Journal of Medicine.